Pivotal bioVenture Partners Fund I U.G.P. Ltd
Related Filers (4)
- Pivotal bioVenture Partners Fund I, L.P. (6)
- Pivotal bioVenture Partners Fund I G.P., L.P. (6)
- Inozyme Pharma, Inc. (4)
- Entasis Therapeutics Holdings Inc. (2)
- Show More ...
Other (13)
13F-NT
Tuesday, 2/13/2024
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/13/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 8/11/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 5/12/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 2/13/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 11/10/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 8/12/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 5/13/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 2/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/15/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 5/14/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/9/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
Ownership (6)
4
Thursday, 8/3/2023
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/20/2022
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/28/2020
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/23/2020
Inozyme Pharma, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 10/2/2018
Entasis Therapeutics Holdings Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/25/2018
Entasis Therapeutics Holdings Inc.: Initial statement of beneficial ownership of securities